Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Protara Therapeutics, Inc.TARA · Entity 6203 | VP, Controller | January 26, 2026 | January 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Protara Therapeutics, Inc.
Report date January 26, 2026 · Filed January 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,723 |
Reported balance
After 2026-01-26 transaction · row 1
1 source rowRow 1 · 2026-01-26 · Tax withholding · Disposed 1,457 · Balance 42,723 F1: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2026 Filed Jan 27, 2026 21:10 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | Tax withholdingCommon Stock | 1,457 | $6.67 | $9,718.19 |
DisclosureSEC source: 0001213900-26-008222 · marketforms-71932.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,723 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:30 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | Tax withholdingCommon Stock | 2,132 | $5.60 | $11,939.20 |
DisclosureSEC source: 0001213900-26-006707 · marketforms-71769.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,180 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001213900-26-006229 · marketforms-71897.xml · derivative · entry 2 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2036-01-15 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantCommon Stock | 9,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-006229 · marketforms-71897.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,312 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 21:05 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $4.53 | $0.00 |
DisclosureSEC source: 0001213900-25-007531 · marketforms-67929.xml · derivative · entry 2 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2035-01-23 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 24, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 21:05 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantCommon Stock | 9,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-007531 · marketforms-67929.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,942 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 24, 2025. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 21:05 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | Tax withholdingCommon Stock | 2,130 | $4.76 | $10,138.80 |
DisclosureSEC source: 0001213900-25-005964 · marketforms-67895.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,312 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 21:20 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | Tax withholdingCommon Stock | 394 | $6.14 | $2,419.16 |
DisclosureSEC source: 0001213900-25-001645 · marketforms-67733.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,442 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantStock Option (Right to Buy) · Derivative | 46,000 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001213900-24-005722 · marketforms-64340.xml · derivative · entry 3 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,000 Underlying: Common Stock · 46,000 shares Expires 2034-01-18 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | Tax withholdingCommon Stock | 904 | $1.91 | $1,726.64 |
DisclosureSEC source: 0001213900-24-005722 · marketforms-64340.xml · nonDerivative · entry 2 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,836 F3 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-005722 · marketforms-64340.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,740 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:05 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | Tax withholdingCommon Stock | 324 | $2.17 | $703.08 |
DisclosureSEC source: 0001213900-24-001512 · marketforms-63995.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,740 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 20:05 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | Tax withholdingCommon Stock | 10,075 | $2.56 | $25,792.00 |
DisclosureSEC source: 0001213900-23-057844 · marketforms-62056.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,064 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on July 16, 2022. Read SEC document |
| January 19, 2023 Filed Jan 20, 2023 21:00 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantStock Option (Right to Buy) · Derivative | 35,400 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-23-004080 · ownership.xml · derivative · entry 2 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,400 Underlying: Common Stock · 35,400 shares Expires 2033-01-18 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 19, 2023 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 19, 2023 Filed Jan 20, 2023 21:00 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantCommon Stock | 5,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-004080 · ownership.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,139 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2023. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 21:24 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | Tax withholdingCommon Stock | 361 | $2.80 | $1,010.80 |
DisclosureSEC source: 0001213900-23-000853 · ownership.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,239 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022. Read SEC document |
| July 16, 2022 Filed Jul 19, 2022 20:06 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-040288 · ownership.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,600 F1 · shares: The shares being reported are being issued pursuant to a restricted stock unit (RSU) award, of which each RSU represents a contingent right to receive one share of Issuer's common stock. The RSUs vest one hundred percent (100%) on the first anniversary of July 16, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.